Status:
UNKNOWN
Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors
Lead Sponsor:
Yonsei Hyperthermia Study Group
Collaborating Sponsors:
Medicon, Inc.
Conditions:
Solid Tumor
Eligibility:
All Genders
19-85 years
Phase:
NA
Brief Summary
The main purpose of this study is to evaluate immunogenic effect of hyperthermia applied with flexible electrode-typed 2-MHz device during radiotherapy for solid tumors.
Eligibility Criteria
Inclusion
- Solid tumor (primary, metastatic)
- Eastern Cooperative Oncology Group (ECOG) score 0-3
- Ability to understand and the willingness to sign a written informed consent documents
Exclusion
- Myocardial infarct, unstable angina, heart failure, uncontrolled arrhythmia within 6 months
- Active infectious disease
- Pregnant or probability of pregnancy during treatment
- Obesity (BMI ≥35)
- Immunosuppressive drug after organ transplantation
- Autoimmune disease
- Skin injury on treatment area
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05282784
Start Date
March 10 2022
End Date
April 30 2022
Last Update
March 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.